<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> is one of the diseases that most compromise the human species </plain></SENT>
<SENT sid="1" pm="."><plain>Therapeutic recovery of blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) disruption represents a novel promising approach to reduce brain injury after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To determine the effects of calcitonin gene-related <z:chebi fb="7" ids="16670">peptide</z:chebi> (CGRP) on the <z:chebi fb="2" ids="33602">BBB</z:chebi> participate in <z:hpo ids='HP_0001297'>stroke</z:hpo> progression, rat <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion injury was induced by a 2-hour left transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) using an intraluminal filament, followed by 46h of reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>CGRP (1μg/ml) at the dose of 3μg/kg (i.p.) was administered at the beginning of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequently, 48h after MCAO, arterial blood pressure, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, water content, <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability, <z:chebi fb="2" ids="33602">BBB</z:chebi> ultrastructure, levels of aquaporin-4 (AQP4) and its <z:chebi fb="2" ids="33699">mRNA</z:chebi> were evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>CGRP could reduce arterial blood pressure (P&lt;0.001), <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (P&lt;0.05), <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> (P&lt;0.01), <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability (P&lt;0.05), AQP4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression (P&lt;0.05) and AQP4 protein expression (P&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, CGRP treatment improved ultrastructural damage of capillary endothelium cells and decreased the loss of the tight junction observed by transmission electronic microscopy (TEM) after 46h of reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings show that CGRP significantly reduced postischemic increase of <z:hpo ids='HP_0002181'>brain edema</z:hpo> with a 2-hour therapeutic window in the transient model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, it seems that at least part of the anti-edematous effects of CGRP is due to decrease of <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption by improving ultrastructural damage of capillary endothelium cells, enhancing basal membrane, and inhibiting AQP4 and its <z:chebi fb="2" ids="33699">mRNA</z:chebi> over-expression </plain></SENT>
<SENT sid="9" pm="."><plain>The data of the present study provide a new possible approach for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> therapy by administration of CGRP </plain></SENT>
</text></document>